Vifor Pharma AG VIFN
The next Vifor Pharma AG dividend will go ex in 2 months for 200c and will be paid in 2 months.
The previous Vifor Pharma AG dividend was 200c and it went ex 10 months ago and it was paid 10 months ago.
There is typically 1 dividend per year (excluding specials).
|Summary||Previous dividend||Next dividend|
|Declaration date||12 Mar 2020 (Thu)||03 Mar 2021 (Wed)|
|Ex-div date||18 May 2020 (Mon)||10 May 2021 (Mon)|
|Pay date||20 May 2020 (Wed)||12 May 2021 (Wed)|
Enter the number of Vifor Pharma AG shares you hold and we'll calculate your dividend payments:
Sign up for Vifor Pharma AG and we'll email you the dividend information when they declare.
Add Vifor Pharma AG to receive free notifications when they declare their dividends.
Your account is set up to receive Vifor Pharma AG notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Final||06 Mar 2025||12 May 2025||14 May 2025||CHF||Sign up||—|
|Forecast||Final||07 Mar 2024||13 May 2024||15 May 2024||CHF||Sign up||—|
|Forecast||Final||09 Mar 2023||15 May 2023||17 May 2023||CHF||Sign up||—|
|Forecast||Final||10 Mar 2022||16 May 2022||18 May 2022||CHF||Sign up||—|
|Declared||Final||03 Mar 2021||10 May 2021||12 May 2021||CHF||200c||200c||😄|
|Paid||Final||12 Mar 2020||18 May 2020||20 May 2020||CHF||200c||200c||😄|
|Paid||Final||14 Mar 2019||10 May 2019||14 May 2019||CHF||—||200c|
|Paid||Final||15 Mar 2018||17 May 2018||22 May 2018||CHF||—||200c|
|Paid||Final||14 Mar 2017||16 May 2017||18 May 2017||CHF||—||2000c|
|Paid||Final||–||03 May 2016||06 May 2016||CHF||—||1800c|
|Paid||Final||–||12 May 2015||15 May 2015||CHF||—||1500c|
|Paid||Final||–||13 May 2014||16 May 2014||CHF||—||1400c|
|Paid||Final||–||06 May 2013||10 May 2013||CHF||—||1100c|
|2021||Sign Up Required|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
Vifor Pharma AG Optimized Dividend Chart
About Vifor Pharma AG
Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its portfolio of renal pharmaceuticals includes products for anaemia management, such as Mircera, mineral and bone management, such as Velphoro, Rayaldee and Osvaren, and cardio-renal management, such as patiromer (in the United States sold under the brand Veltassa). The Company also conducts research in the area of infectious and rare diseases, partnering with other biopharmaceutical companies. The Company has production sites in Switzerland and Portugal as well as a network of affiliates and partners around the world.
- Health Care Equipment & Services
- Share Price
- Fr.116.95 (yesterday's closing price)
- Shares in Issue
- 65 million
- Market Cap
- Market Indices